[Federal Register Volume 64, Number 170 (Thursday, September 2, 1999)] [Notices] [Pages 48179-48180] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 99-22860] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [INFO-99-28] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call the CDC Reports Clearance Officer on (404) 639-7090. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques for other forms of information technology. Send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 30333. Written comments should be received within 60 days of this notice. Proposed Project Translating Research Into Action for Diabetes (TRIAD)--New--The National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Division of Diabetes Translation. Diabetes exerts a huge public health burden, and there are several efficacious interventions to combat the effects of this disease. Yet, the quality of care and quality of life among people with diabetes remain sub-optimal in the United States. The Centers for Disease Control and Prevention, Division of Diabetes Translation, intends to conduct a multi-center study called Translating Research Into Action for Diabetes (TRIAD). This study will assess quality of diabetes care and identify effective means of applying existing knowledge to improve care and quality of life. Data provided from TRIAD will be critical to the Division of Diabetes Translation's ongoing efforts to reduce the burden of diabetes. Data will be collected through cooperative agreements with six [[Page 48180]] Managed Care Organizations (MCOs). Each MCO will provide data on organization of care, details of diabetes interventions, and efforts to improve diabetes care collected from interviews of health plan and provider group directors. Each MCO will also provide data from random samples of its diabetic members collected via computer-assisted telephone interviews (CATIs). Information from plan members will include demography, quality of diabetes care, quality of life, satisfaction with care, diabetes severity and duration, and barriers to care. Each MCO will collect data from directors and diabetic members at baseline and after two years of follow-up. The total cost to respondents is estimated at $1,620,000. ---------------------------------------------------------------------------------------------------------------- Number of Avg. burden of Respondent Number of respondents responses/ response (In Total burden respondent hrs.) (In hrs.) ---------------------------------------------------------------------------------------------------------------- Managed Care Organizations (MCOs)..... 6 MCOs--(each respondent 2 0.75 27,000 MCO will provide information from an average of 3,000 plan members and directors). ------------------------------------------------------------------------- Total............................. ........................ .............. .............. 27,000 ---------------------------------------------------------------------------------------------------------------- Dated: August 24, 1999. Nancy Cheal, Acting Associate Director for Policy, Planning and Evaluation, Centers for Disease Control and Prevention (CDC). [FR Doc. 99-22860 Filed 9-1-99; 8:45 am] BILLING CODE 4163-18-P